These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Potassium-escape-phenomenon in rats during continuous application of amiloride. 3. Influence of acid and alkali loading. Hohenegger M, Marktl W, Selzer H. Pharmacology; 1971; 6(5):308-16. PubMed ID: 5143211 [No Abstract] [Full Text] [Related]
26. Amiloride hydrochloride in hypertensive patients. Paterson JW, Dollery CT, Haslam RM. Br Med J; 1968 Feb 17; 1(5589):422-3. PubMed ID: 5639627 [No Abstract] [Full Text] [Related]
27. [Association of furosemide and amiloride in patients with essential hypertension. Effect on the excretion of Na, K, Cl and on urine volume]. Chávez de Los Rios JM, Otero Cagide F, Alfaro Cano L, Gatica Laborde V. Prensa Med Mex; 1978 Feb 17; 43(3-4):89-94. PubMed ID: 364462 [No Abstract] [Full Text] [Related]
28. Clinical trial of a potassium-sparing saluretic pyrazine derivative (MK-870). Lundvall O, Berlind S. Acta Med Scand; 1967 Apr 17; 181(4):457-63. PubMed ID: 6024860 [No Abstract] [Full Text] [Related]
29. [Diuretic treatment of arterial hypertension. Value of potassium sparing]. Blatrix C. Therapeutique; 1972 Dec 17; 48(10):663-6. PubMed ID: 4661291 [No Abstract] [Full Text] [Related]
32. Diuretics, cardiac failure and potassium depletion: a rational approach. Whight C, Morgan T, Carney S, Wilson M. Med J Aust; 1974 Dec 07; 2(23):831-3. PubMed ID: 4217884 [No Abstract] [Full Text] [Related]
33. Clinical experience with amiloride in the elderly. Macfarlane JP, Kennedy RD. Acta Cardiol; 1973 Dec 07; 28(3):365-74. PubMed ID: 4543134 [No Abstract] [Full Text] [Related]
34. Possible predisposition of diabetic patients to hyperkalemia following administration of potassium-retaining diuretic, amiloride (MK 870). McNay JL, Oran E. Metabolism; 1970 Jan 07; 19(1):58-70. PubMed ID: 5410663 [No Abstract] [Full Text] [Related]